All-cause claims analysis of the LATERA absorbable nasal implant vs surgical repair in patients with nasal valve collapse.

IF 2.9 4区 医学 Q2 HEALTH CARE SCIENCES & SERVICES
Journal of Medical Economics Pub Date : 2024-01-01 Epub Date: 2024-08-23 DOI:10.1080/13696998.2024.2362046
Ricky Vo, Yazid Barhoush, Lakshmi Batchu, Shayna Adams, Gavin Setzen
{"title":"All-cause claims analysis of the LATERA absorbable nasal implant vs surgical repair in patients with nasal valve collapse.","authors":"Ricky Vo, Yazid Barhoush, Lakshmi Batchu, Shayna Adams, Gavin Setzen","doi":"10.1080/13696998.2024.2362046","DOIUrl":null,"url":null,"abstract":"<p><strong>Aims: </strong>To compare all-cause claims associated with the LATERA Absorbable Nasal Implant and surgical repair of nasal vestibular stenosis in patients with nasal valve collapse.</p><p><strong>Methods: </strong>This retrospective cohort study utilized data from STATinMED RWD Insights. A defined set of HCPCS, ICD-10-CM and CPT codes were used to identify patients with ≥1 claim for a LATERA procedure, and patients with ≥1 claim for surgical repair between June 1, 2015- March 31, 2023. Patients with continuous capture for at least 12 months before and at least 6 months after the index date were selected. The index date was defined as earliest date of encounter for a LATERA or surgical repair procedure. Inverse probability of treatment weighting (IPTW) was used to ensure balance between cohorts. Descriptive analyses were provided for all claims data using standard summary statistics. All-cause claims were assessed during the baseline, index date, and follow-up period. Chi-squared tests and independent sample t-tests were used to assess differences in cohorts for categorical and continuous variables, respectively.</p><p><strong>Results: </strong>The study population included 5,032 LATERA patients and 26,553 surgical repair patients. During the baseline and follow-up periods, the matched cohorts exhibited similar all-cause claims. On the index date, LATERA patients incurred lower claims vs. surgical repair, likely due to LATERA's ability to be implanted in the physician office setting. LATERA patients and surgical repair patients mean (SD) total costs were $9,612 [$14,930] vs $11,846 [$17,037] (<i>p</i> ≤ 0.0001), respectively.</p><p><strong>Conclusions: </strong>Treatment with the LATERA Absorbable Nasal Implant is a potentially cost saving option for payers on the index date compared to traditional surgical repair in patients with nasal valve collapse due to the ability to be performed in the office. All-cause claims were similar in the baseline and follow-up periods. When performed with concomitant procedures, all-cause claims during follow-up were similar between groups.</p>","PeriodicalId":16229,"journal":{"name":"Journal of Medical Economics","volume":" ","pages":"1099-1107"},"PeriodicalIF":2.9000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Medical Economics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/13696998.2024.2362046","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/8/23 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0

Abstract

Aims: To compare all-cause claims associated with the LATERA Absorbable Nasal Implant and surgical repair of nasal vestibular stenosis in patients with nasal valve collapse.

Methods: This retrospective cohort study utilized data from STATinMED RWD Insights. A defined set of HCPCS, ICD-10-CM and CPT codes were used to identify patients with ≥1 claim for a LATERA procedure, and patients with ≥1 claim for surgical repair between June 1, 2015- March 31, 2023. Patients with continuous capture for at least 12 months before and at least 6 months after the index date were selected. The index date was defined as earliest date of encounter for a LATERA or surgical repair procedure. Inverse probability of treatment weighting (IPTW) was used to ensure balance between cohorts. Descriptive analyses were provided for all claims data using standard summary statistics. All-cause claims were assessed during the baseline, index date, and follow-up period. Chi-squared tests and independent sample t-tests were used to assess differences in cohorts for categorical and continuous variables, respectively.

Results: The study population included 5,032 LATERA patients and 26,553 surgical repair patients. During the baseline and follow-up periods, the matched cohorts exhibited similar all-cause claims. On the index date, LATERA patients incurred lower claims vs. surgical repair, likely due to LATERA's ability to be implanted in the physician office setting. LATERA patients and surgical repair patients mean (SD) total costs were $9,612 [$14,930] vs $11,846 [$17,037] (p ≤ 0.0001), respectively.

Conclusions: Treatment with the LATERA Absorbable Nasal Implant is a potentially cost saving option for payers on the index date compared to traditional surgical repair in patients with nasal valve collapse due to the ability to be performed in the office. All-cause claims were similar in the baseline and follow-up periods. When performed with concomitant procedures, all-cause claims during follow-up were similar between groups.

对鼻瓣膜塌陷患者进行的 LATERA 可吸收鼻腔植入物与手术修复的全因索赔分析。
目的:比较鼻瓣膜塌陷患者使用 LATERA 可吸收鼻腔植入物和手术修复鼻前庭狭窄相关的全因索赔:这项回顾性队列研究利用了 STATinMED RWD Insights 的数据。研究人员使用一组定义的 HCPCS、ICD-10-CM 和 CPT 代码来识别在 2015 年 6 月 1 日至 2023 年 3 月 31 日期间 LATERA 手术索赔次数≥1 次的患者和手术修复索赔次数≥1 次的患者。选取在指数日期之前至少 12 个月和之后至少 6 个月连续采集的患者。指数日期定义为 LATERA 或外科修复手术的最早就诊日期。采用反向治疗概率加权法 (IPTW) 确保各组群之间的平衡。所有理赔数据均使用标准汇总统计进行描述性分析。对基线、指数日和随访期间的全因索赔进行了评估。采用卡方检验(Chi-squared tests)和独立样本 t 检验(independent sample t-tests )分别评估分类变量和连续变量的组群差异:研究对象包括 5,032 名 LATERA 患者和 26,553 名手术修复患者。在基线和随访期间,配对队列的全因索赔情况相似。在指数日,LATERA 患者的索赔额低于手术修复患者,这可能是由于 LATERA 可以在医生诊室植入。LATERA患者和手术修复患者的平均(标度)总费用分别为9612美元[14930美元] vs 11846美元[17037美元](P≤0.0001):与传统的手术修复相比,LATERA 可吸收鼻腔植入物治疗鼻瓣膜塌陷患者可在诊室内进行,因此可为付款人在指数日节省费用。基线期和随访期的全因索赔相似。在同时进行手术的情况下,各组随访期间的全因索赔额相似。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Medical Economics
Journal of Medical Economics HEALTH CARE SCIENCES & SERVICES-MEDICINE, GENERAL & INTERNAL
CiteScore
4.50
自引率
4.20%
发文量
122
期刊介绍: Journal of Medical Economics'' mission is to provide ethical, unbiased and rapid publication of quality content that is validated by rigorous peer review. The aim of Journal of Medical Economics is to serve the information needs of the pharmacoeconomics and healthcare research community, to help translate research advances into patient care and be a leader in transparency/disclosure by facilitating a collaborative and honest approach to publication. Journal of Medical Economics publishes high-quality economic assessments of novel therapeutic and device interventions for an international audience
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信